Hua Yuan Zheng Quan·2025-11-06 02:30Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The report highlights that China Life's new business sales have shown strong improvement quarter by quarter, with significant growth in investment income [5] - In Q3 2025, the company's revenue and net profit attributable to shareholders increased by 54.8% and 91.5% year-on-year, reaching 298.7 billion yuan and 126.9 billion yuan respectively [5] - The report indicates that the company's net asset value grew by 22.8% year-to-date, reaching 625.8 billion yuan, and the new business value (NBV) increased by 41.8% [5][11] Financial Performance - The company's Q3 2025 net profit reached 126.9 billion yuan, a 91.5% increase from Q3 2024, driven by reduced insurance service costs and strong new business sales [8][11] - The total investment income for the first three quarters of 2025 increased by 41% to 368.6 billion yuan, with an investment return rate of 6.42%, up 104 basis points year-on-year [13] - The report projects the company's net profit for 2025-2027 to be 173.5 billion, 153.8 billion, and 186.4 billion yuan respectively, with year-on-year growth rates of 62%, -11.4%, and 21.2% [11][22] Business Development - The company has shown a clear trend of improving new policy sales, with a year-on-year growth rate of 52.5% in Q3 2025 [8][11] - The report notes that the sales team has improved its skills in selling floating-rate products, contributing to the strong sales performance [8] - The company is expected to perform well in the 2026 sales season, supported by a stable sales team and improved retention rates [8]